{"id":549635,"date":"2026-04-17T05:03:30","date_gmt":"2026-04-17T03:03:30","guid":{"rendered":"https:\/\/www.dynseo.com\/sclerose-en-plaques-sep-symptomes-et-prise-en-charge-dynseo-2\/"},"modified":"2026-04-17T05:04:27","modified_gmt":"2026-04-17T03:04:27","slug":"sclerosi-multipla-sep-sintomi-e-gestione-dynseo","status":"publish","type":"post","link":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/","title":{"rendered":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Article HTML&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Contenu&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_code admin_label=&#8221;HTML import\u00e9&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<style type=\"text\/css\">\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Montserrat:wght@600;700;800&family=Poppins:wght@400;500;600&display=swap');\n        * { margin: 0; padding: 0; box-sizing: border-box; }\n.dbi-art-d20b5e { font-family: 'Poppins', sans-serif; line-height: 1.8; color: #333; background-color: #f8f9fa; }\n.dbi-art-d20b5e .container { max-width: 900px; margin: 0 auto; padding: 20px; }\n.dbi-art-d20b5e .article-header { background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 60px 20px; text-align: center; border-radius: 0 0 30px 30px; margin-bottom: 40px; }\n.dbi-art-d20b5e .article-category { display: inline-block; background: rgba(255,255,255,0.2); padding: 8px 20px; border-radius: 25px; font-size: 0.9rem; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-header h1 { font-family: 'Montserrat', sans-serif; font-size: 2.3rem; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-header .subtitle { font-size: 1.1rem; opacity: 0.95; max-width: 700px; margin: 0 auto; }\n.dbi-art-d20b5e .intro-paragraph { font-size: 1.1rem; color: #555; padding: 30px; background: white; border-radius: 15px; border-left: 5px solid #5e5ed7; margin-bottom: 40px; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e h2 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; font-size: 1.9rem; margin: 50px 0 25px; padding-bottom: 15px; border-bottom: 3px solid #a9e2e4; }\n.dbi-art-d20b5e h3 { font-family: 'Montserrat', sans-serif; color: #5268c9; font-size: 1.35rem; margin: 35px 0 15px; }\n.dbi-art-d20b5e p { margin-bottom: 20px; text-align: justify; }\n.dbi-art-d20b5e .highlight-box { background: linear-gradient(135deg, #a9e2e4 0%, #d0f0f2 100%); padding: 30px; border-radius: 15px; margin: 30px 0; }\n.dbi-art-d20b5e .highlight-box h4 { font-family: 'Montserrat', sans-serif; color: #5268c9; margin-bottom: 15px; font-size: 1.2rem; }\n.dbi-art-d20b5e .tip-box { background: linear-gradient(135deg, #ffeca7 0%, #ffe88a 100%); padding: 25px; border-radius: 15px; margin: 25px 0; }\n.dbi-art-d20b5e .tip-box h4 { font-family: 'Montserrat', sans-serif; color: #5268c9; margin-bottom: 10px; }\n.dbi-art-d20b5e .warning-box { background: linear-gradient(135deg, #fde8ee 0%, #fcc8d6 100%); padding: 25px; border-radius: 15px; margin: 25px 0; border-left: 5px solid #e73469; }\n.dbi-art-d20b5e .warning-box h4 { font-family: 'Montserrat', sans-serif; color: #e73469; margin-bottom: 10px; }\n.dbi-art-d20b5e .stats-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 20px; margin: 30px 0; }\n.dbi-art-d20b5e .stat-card { background: white; padding: 25px; border-radius: 15px; text-align: center; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e .stat-number { font-family: 'Montserrat', sans-serif; font-size: 2.5rem; font-weight: 800; color: #5e5ed7; display: block; }\n.dbi-art-d20b5e .stat-label { color: #666; font-size: 0.9rem; margin-top: 8px; }\n.dbi-art-d20b5e .comparison-table { width: 100%; border-collapse: collapse; margin: 30px 0; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e .comparison-table th { background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 15px 20px; text-align: left; font-family: 'Montserrat', sans-serif; }\n.dbi-art-d20b5e .comparison-table td { padding: 14px 20px; border-bottom: 1px solid #f0f0ff; background: white; vertical-align: top; }\n.dbi-art-d20b5e .comparison-table tr:last-child td { border-bottom: none; }\n.dbi-art-d20b5e .comparison-table tr:nth-child(even) td { background: #f8f8ff; }\n.dbi-art-d20b5e .program-card { background: white; border-radius: 20px; box-shadow: 0 8px 30px rgba(94,94,215,0.15); margin: 40px 0; padding: 30px; }\n.dbi-art-d20b5e .program-card h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; font-size: 1.4rem; margin-bottom: 15px; }\n.dbi-art-d20b5e .cta-button { display: inline-block; background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 14px 32px; border-radius: 30px; text-decoration: none; font-weight: 600; margin-top: 15px; }\n.dbi-art-d20b5e .method-card { background: white; border-radius: 15px; padding: 28px; margin: 22px 0; box-shadow: 0 5px 20px rgba(94,94,215,0.08); }\n.dbi-art-d20b5e .method-card.blue { border-left: 4px solid #5e5ed7; }\n.dbi-art-d20b5e .method-card.teal { border-left: 4px solid #a9e2e4; }\n.dbi-art-d20b5e .method-card.rose { border-left: 4px solid #e73469; }\n.dbi-art-d20b5e .method-card.yellow { border-left: 4px solid #ffeca7; border-top: 3px solid #ffeca7; }\n.dbi-art-d20b5e .method-card h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 12px; font-size: 1.1rem; }\n.dbi-art-d20b5e .method-card.teal h4 { color: #5268c9; }\n.dbi-art-d20b5e .method-card.rose h4 { color: #e73469; }\n.dbi-art-d20b5e .method-badge { display: inline-block; padding: 4px 12px; border-radius: 20px; font-size: 0.8rem; font-weight: 600; margin-bottom: 12px; }\n.dbi-art-d20b5e .badge-blue { background: #f0f0ff; color: #5e5ed7; }\n.dbi-art-d20b5e .badge-green { background: #e0f7f8; color: #5268c9; }\n.dbi-art-d20b5e .badge-rose { background: #fde8ee; color: #e73469; }\n.dbi-art-d20b5e .badge-yellow { background: #fff8dc; color: #8a6d00; }\n.dbi-art-d20b5e .checklist { background: white; padding: 30px; border-radius: 15px; box-shadow: 0 5px 20px rgba(94,94,215,0.1); margin: 25px 0; }\n.dbi-art-d20b5e .checklist h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 20px; }\n.dbi-art-d20b5e .checklist ul { list-style: none; padding: 0; }\n.dbi-art-d20b5e .checklist li { padding: 10px 0; border-bottom: 1px solid #f0f0ff; padding-left: 35px; position: relative; }\n.dbi-art-d20b5e .checklist li::before { content: '\u2714'; position: absolute; left: 0; color: #5e5ed7; font-weight: bold; }\n.dbi-art-d20b5e .checklist li:last-child { border-bottom: none; }\n.dbi-art-d20b5e .conclusion { background: linear-gradient(135deg, #f5f7fa 0%, #e8e8ff 100%); padding: 40px; border-radius: 20px; margin-top: 50px; }\n.dbi-art-d20b5e .conclusion h2 { border-bottom: none; margin-top: 0; }\n.dbi-art-d20b5e .article-footer { text-align: center; padding: 50px 20px; background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; border-radius: 30px 30px 0 0; margin-top: 60px; }\n.dbi-art-d20b5e .article-footer h3 { font-family: 'Montserrat', sans-serif; color: white; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-footer a { color: #ffeca7; text-decoration: none; font-weight: 600; }\n.dbi-art-d20b5e .footer-links { display: flex; gap: 20px; justify-content: center; flex-wrap: wrap; margin-top: 15px; }\n.dbi-art-d20b5e .faq-item { background: white; border-radius: 15px; padding: 25px 30px; margin: 15px 0; box-shadow: 0 3px 15px rgba(94,94,215,0.08); border-left: 4px solid #a9e2e4; }\n.dbi-art-d20b5e .faq-item h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 12px; font-size: 1.05rem; }\n.dbi-art-d20b5e .faq-item p { margin: 0; color: #555; }\n.dbi-art-d20b5e a { color: #5e5ed7; }\n@media (max-width: 768px) {\n.dbi-art-d20b5e .article-header h1 { font-size: 1.8rem; }\n.dbi-art-d20b5e .stats-grid { grid-template-columns: 1fr; }\n.dbi-art-d20b5e .article-header { padding: 40px 15px; }\n.dbi-art-d20b5e .container { padding: 15px; }\n.dbi-art-d20b5e h2 { font-size: 1.5rem; }\n.dbi-art-d20b5e .comparison-table { font-size: 0.9rem; }\n}<\/p>\n<\/style>\n<div class=\"dbi-art-d20b5e\">\n<article>\n<header class=\"article-header\">\n<div class=\"article-category\">\ud83e\udde0 Malattie neurodegenerative \u2014 Serie SEP\/SLA\/Parkinson<\/div>\n<h1>Sclerosi multipla (SEP): sintomi e gestione<\/h1>\n<pee class=\"subtitle\">La SEP colpisce 120.000 persone in Francia, principalmente donne giovani. Malattia autoimmune complessa, i suoi sintomi variano da persona a persona e evolvono in modo imprevedibile. Questa guida fa il punto.<\/pee>\n<\/header>\n<div class=\"container\">\n<div class=\"intro-paragraph\">\nLa sclerosi multipla \u00e8 una delle malattie neurologiche croniche pi\u00f9 frequenti negli adulti giovani. Prima causa di disabilit\u00e0 non traumatica di origine neurologica prima dei 50 anni in Francia, si caratterizza per un&#8217;imprevedibilit\u00e0 che rende il suo accompagnamento particolarmente complesso. Comprendere i suoi meccanismi, le sue forme cliniche e i suoi sintomi \u2014 in particolare i disturbi cognitivi spesso poco conosciuti \u2014 \u00e8 il primo passo per accompagnare efficacemente le persone che ne sono colpite.\n<\/div>\n<div class=\"stats-grid\">\n<div class=\"stat-card\"><span class=\"stat-number\">120 000<\/span><\/p>\n<div class=\"stat-label\">persone affette da SEP in Francia \u2014 3 nuove diagnosi al giorno<\/div>\n<\/div>\n<div class=\"stat-card\"><span class=\"stat-number\">85%<\/span><\/p>\n<div class=\"stat-label\">dei casi sono di forma ricorrente-remittente \u2014 con riacutizzazioni e remissioni<\/div>\n<\/div>\n<div class=\"stat-card\"><span class=\"stat-number\">40\u201370%<\/span><\/p>\n<div class=\"stat-label\">presentano disturbi cognitivi in un momento della malattia<\/div>\n<\/div>\n<\/div>\n<h2>1. Meccanismo e definizione<\/h2>\n<pee>La SEP \u00e8 una malattia autoimmune in cui il sistema immunitario attacca per errore la <strong>mielina<\/strong>, la guaina isolante che circonda le fibre nervose del sistema nervoso centrale (cervello e midollo spinale). Questo attacco forma placche di demielinizzazione che perturbano o bloccano la trasmissione dei messaggi nervosi. Con il tempo, alcune fibre nervose sono anche danneggiate irreparabilmente \u2014 \u00e8 la neurodegenerazione che genera la disabilit\u00e0 progressiva.<\/pee>\n<pee>La SEP colpisce preferenzialmente le donne (rapporto di sesso 3:1), con un picco di diagnosi tra i 20 e i 40 anni. La sua eziologia \u00e8 multifattoriale: predisposizione genetica (25% di concordanza tra gemelli monozigoti), fattori ambientali (carenza di vitamina D, fumo, infezione da virus di Epstein-Barr) e fattori immunologici.<\/pee>\n<h2>2. Le forme cliniche<\/h2>\n<table class=\"comparison-table\">\n<thead>\n<tr>\n<th>Forma<\/th>\n<th>Frequenza<\/th>\n<th>Evoluzione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Ricorrente-remittente (RR)<\/strong><\/td>\n<td>85 %<\/td>\n<td>Riacutizzazioni separate da periodi di stabilit\u00e0 (remissioni parziali o complete)<\/td>\n<\/tr>\n<tr>\n<td><strong>Progressiva primaria (PP)<\/strong><\/td>\n<td>15 %<\/td>\n<td>Deterioramento progressivo sin dall&#8217;inizio, senza riacutizzazioni distinte<\/td>\n<\/tr>\n<tr>\n<td><strong>Progressiva secondaria (PS)<\/strong><\/td>\n<td>Variabile<\/td>\n<td>Evoluzione da una forma RR verso una progressione continua<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>3. Sintomi<\/h2>\n<div class=\"method-card blue\">\n<div class=\"method-badge badge-blue\">\ud83d\ude34 Fatica neurologica<\/div>\n<h4>La fatica SEP: molto pi\u00f9 della fatica ordinaria<\/h4>\n<pee>Presente nell&#8217;80% dei pazienti, la fatica nella SEP \u00e8 una fatica neurologica profonda e spesso sproporzionata rispetto allo sforzo. Non si allevia con il riposo, peggiora con il caldo (fenomeno di Uhthoff \u2014 il caldo rallenta ulteriormente la conduzione nervosa demielinizzata) e pu\u00f2 verificarsi anche nei giorni di remissione. \u00c8 spesso il sintomo pi\u00f9 invalidante nella vita quotidiana e professionale.<\/pee>\n<\/div>\n<div class=\"method-card teal\">\n<div class=\"method-badge badge-green\">\ud83d\udc41\ufe0f Sensitivo e motorio<\/div>\n<h4>Sintomi classici<\/h4>\n<pee>I disturbi sensitivi (formicolii, intorpidimenti, dolori neuropatici) sono spesso i primi segni. I <strong>disturbi visivi<\/strong> \u2014 neurite ottica con visione offuscata e dolore oculare \u2014 colpiscono il 20-25% dei pazienti alla prima riacutizzazione. La <strong>spasticit\u00e0<\/strong> (muscoli rigidi e contratti), i <strong>disturbi dell&#8217;equilibrio<\/strong> e la <strong>fatica muscolare<\/strong> caratterizzano la progressione.<\/pee>\n<\/div>\n<div class=\"method-card rose\">\n<div class=\"method-badge badge-rose\">\ud83e\udde0 Cognitivo<\/div>\n<h4>Disturbi cognitivi: la disabilit\u00e0 invisibile della SEP<\/h4>\n<pee>40 a 70% delle persone affette da SEP presentano disturbi cognitivi: <strong>rallentamento del trattamento delle informazioni<\/strong> (compiti che richiedono pi\u00f9 tempo), <strong>disturbi della memoria di lavoro<\/strong> (difficolt\u00e0 a trattenere e manipolare informazioni), <strong>disturbi dell&#8217;attenzione divisa<\/strong> (difficolt\u00e0 a gestire pi\u00f9 compiti contemporaneamente) e <strong>disturbi delle funzioni esecutive<\/strong>. Questi disturbi sono spesso invisibili ma profondamente impattanti sull&#8217;occupazione e sulle relazioni.<\/pee>\n<\/div>\n<h2>4. Trattamenti<\/h2>\n<pee>La gestione della SEP si basa su tre assi. I <strong>trattamenti di fondo<\/strong> (interferoni, acetato di glatiramer, natalizumab, ocrelizumab) riducono la frequenza e la gravit\u00e0 delle riacutizzazioni e rallentano la progressione \u2014 ma non guariscono la malattia. Il <strong>trattamento delle riacutizzazioni<\/strong> (corticosteroidi in infusione) accelera il recupero durante gli episodi acuti. La <strong>riabilitazione e l&#8217;accompagnamento sintomatico<\/strong> (fisioterapia, terapia occupazionale, logopedia, neuropsicologia) mantengono la qualit\u00e0 della vita e l&#8217;autonomia.<\/pee>\n<div class=\"program-card\">\n<h4>\ud83e\udde0 Formazioni e strumenti DYNSEO per la SEP<\/h4>\n<pee>\u2022 <a href=\"https:\/\/www.dynseo.com\/it\/courses\/sep-e-vita-quotidiana-mantenere-lautonomia-e-prevenire-le-complicazioni-it\/\" target=\"_blank\"><strong>Formazione &#8220;SEP e vita quotidiana&#8221;<\/strong><\/a> \u2014 mantenere l&#8217;autonomia<!\u2013- [et_pb_br_holder] -\u2013><br \/>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/it\/courses\/sclerosi-multipla-in-istituto-comprendere-la-malattia-e-adattare-la-propria-pratica-professionale-it\/\" target=\"_blank\"><strong>Formazione &#8220;SEP in istituto&#8221;<\/strong><\/a> \u2014 adattare la propria pratica<!\u2013- [et_pb_br_holder] -\u2013><br \/>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/it\/courses\/affaticamento-e-disturbi-cognitivi-nella-sclerosi-multipla-cosa-possono-fare-le-famiglie-it\/\" target=\"_blank\"><strong>Formazione &#8220;Fatica e disturbi cognitivi nella SEP&#8221;<\/strong><\/a><!\u2013- [et_pb_br_holder] -\u2013><br \/>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/it\/test-di-memoria\/\" target=\"_blank\"><strong>Test Memoria DYNSEO<\/strong><\/a> \u2014 valutare l&#8217;impatto cognitivo<!\u2013- [et_pb_br_holder] -\u2013><br \/>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/it\/i-nostri-strumenti\/\" target=\"_blank\"><strong>62 strumenti di stimolazione cognitiva<\/strong><\/a><\/pee>\n<a href=\"https:\/\/www.dynseo.com\/it\/courses\/sep-e-vita-quotidiana-mantenere-lautonomia-e-prevenire-le-complicazioni-it\/\" target=\"_blank\" class=\"cta-button\">Scoprire le formazioni SEP \u2192<\/a>\n<\/div>\n<h2>FAQ<\/h2>\n<div class=\"faq-item\">\n<h4>Che cos&#8217;\u00e8 la SEP?<\/h4>\n<pee>Malattia autoimmune del sistema nervoso centrale in cui il sistema immunitario attacca la mielina. Colpisce 120.000 persone in Francia, principalmente donne giovani.<\/pee><\/div>\n<div class=\"faq-item\">\n<h4>Quali sono le forme della SEP?<\/h4>\n<pee>Ricorrente-remittente (85%, riacutizzazioni e remissioni), progressiva primaria (15%, deterioramento continuo) e progressiva secondaria (evoluzione dalla forma RR).<\/pee><\/div>\n<div class=\"faq-item\">\n<h4>La fatica SEP \u00e8 diversa?<\/h4>\n<pee>S\u00ec \u2014 \u00e8 una fatica neurologica profonda, sproporzionata, non alleviata dal riposo, aggravata dal caldo. Colpisce l&#8217;80% dei pazienti ed \u00e8 spesso il sintomo pi\u00f9 invalidante.<\/pee><\/div>\n<div class=\"faq-item\">\n<h4>La SEP influisce sulla cognizione?<\/h4>\n<pee>S\u00ec \u2014 40-70% dei pazienti presentano disturbi cognitivi: rallentamento, memoria di lavoro, attenzione divisa. Questi disturbi sono spesso invisibili ma profondamente impattanti sull&#8217;occupazione e sulla vita sociale.<\/pee><\/div>\n<div class=\"faq-item\">\n<h4>La SEP si guarisce?<\/h4>\n<pee>Non ancora. I trattamenti di fondo riducono la frequenza delle riacutizzazioni e rallentano la progressione. La ricerca avanza sulla remielinizzazione.<\/pee><\/div>\n<div class=\"conclusion\">\n<h2>Conclusione: vivere con la SEP<\/h2>\n<pee>La SEP \u00e8 una malattia complessa, imprevedibile e multidimensionale. I suoi sintomi cognitivi, spesso ignorati a favore dei sintomi motori visibili, meritano un&#8217;attenzione particolare e un accompagnamento specializzato. DYNSEO propone formazioni per i pazienti, i familiari e i professionisti, oltre a strumenti di stimolazione cognitiva adattati alle esigenze specifiche delle persone affette da SEP.<\/pee>\n<\/div>\n<\/div>\n<footer class=\"article-footer\">\n<h3>Risorse DYNSEO \u2014 SEP<\/h3>\n<div class=\"footer-links\">\n<a href=\"https:\/\/www.dynseo.com\/it\/courses\/sep-e-vita-quotidiana-mantenere-lautonomia-e-prevenire-le-complicazioni-it\/\" target=\"_blank\">SEP vita quotidiana<\/a><br \/>\n<a href=\"https:\/\/www.dynseo.com\/it\/courses\/affaticamento-e-disturbi-cognitivi-nella-sclerosi-multipla-cosa-possono-fare-le-famiglie-it\/\" target=\"_blank\">Fatica SEP<\/a><br \/>\n<a href=\"https:\/\/www.dynseo.com\/it\/test-di-memoria\/\" target=\"_blank\">Test Memoria<\/a><br \/>\n<a href=\"https:\/\/www.dynseo.com\/it\/i-nostri-strumenti\/\" target=\"_blank\">62 strumenti<\/a>\n<\/div>\n<\/footer>\n<\/article>\n<\/div>\n<p>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n<p>[et_pb_code]<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Qu'est-ce que la scl\u00e9rose en plaques et comment se d\u00e9veloppe-t-elle ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La scl\u00e9rose en plaques (SEP) est une maladie auto-immune dans laquelle le syst\u00e8me immunitaire attaque par erreur la my\u00e9line, la gaine isolante qui entoure les fibres nerveuses du syst\u00e8me nerveux central (cerveau et moelle \u00e9pini\u00e8re). Cette attaque forme des plaques de d\u00e9my\u00e9linisation qui perturbent ou bloquent la transmission des messages nerveux, entra\u00eenant avec le temps une neurod\u00e9g\u00e9n\u00e9rescence.\"}},{\"@type\":\"Question\",\"name\":\"Combien de personnes sont touch\u00e9es par la SEP en France ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP touche 120 000 personnes en France, principalement des femmes jeunes. On compte environ 3 nouveaux diagnostics par jour. C'est la premi\u00e8re cause de handicap non traumatique d'origine neurologique avant 50 ans en France.\"}},{\"@type\":\"Question\",\"name\":\"Quelle est la forme la plus courante de scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"85% des cas de SEP sont de forme r\u00e9currente-r\u00e9mittente, caract\u00e9ris\u00e9e par des pouss\u00e9es suivies de p\u00e9riodes de r\u00e9mission. Cette forme se distingue par son \u00e9volution impr\u00e9visible avec des phases d'aggravation et d'am\u00e9lioration des sympt\u00f4mes.\"}},{\"@type\":\"Question\",\"name\":\"Les troubles cognitifs sont-ils fr\u00e9quents dans la scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui, 40 \u00e0 70% des personnes atteintes de SEP pr\u00e9sentent des troubles cognitifs \u00e0 un moment de la maladie. Ces troubles cognitifs sont souvent m\u00e9connus mais constituent un aspect important de la maladie qui n\u00e9cessite une prise en charge adapt\u00e9e.\"}},{\"@type\":\"Question\",\"name\":\"Pourquoi dit-on que la SEP est une maladie complexe \u00e0 accompagner ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP est complexe \u00e0 accompagner en raison de son impr\u00e9visibilit\u00e9. Ses sympt\u00f4mes varient d'une personne \u00e0 l'autre et \u00e9voluent de fa\u00e7on impr\u00e9visible, ce qui rend l'accompagnement particuli\u00e8rement difficile et n\u00e9cessite une approche personnalis\u00e9e.\"}},{\"@type\":\"Question\",\"name\":\"Quelle population est principalement touch\u00e9e par la scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP touche principalement des femmes jeunes et constitue l'une des maladies neurologiques chroniques les plus fr\u00e9quentes chez les adultes jeunes. Elle repr\u00e9sente la premi\u00e8re cause de handicap non traumatique d'origine neurologique avant l'\u00e2ge de 50 ans.\"}}]}<\/script>[\/et_pb_code]<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":150367,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[et_pb_section fb_built=\"1\" admin_label=\"Article HTML\" _builder_version=\"4.16\" custom_padding=\"0px||0px||false|false\" global_colors_info=\"{}\"][et_pb_row admin_label=\"Contenu\" _builder_version=\"4.16\" width=\"100%\" max_width=\"100%\" custom_padding=\"0px||0px||false|false\" global_colors_info=\"{}\"][et_pb_column type=\"4_4\" _builder_version=\"4.16\" global_colors_info=\"{}\"][et_pb_code admin_label=\"HTML import\u00e9\" _builder_version=\"4.16\" global_colors_info=\"{}\"]<style type=\"text\/css\">\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Montserrat:wght@600;700;800&family=Poppins:wght@400;500;600&display=swap');\n        * { margin: 0; padding: 0; box-sizing: border-box; }\n.dbi-art-d20b5e { font-family: 'Poppins', sans-serif; line-height: 1.8; color: #333; background-color: #f8f9fa; }\n.dbi-art-d20b5e .container { max-width: 900px; margin: 0 auto; padding: 20px; }\n.dbi-art-d20b5e .article-header { background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 60px 20px; text-align: center; border-radius: 0 0 30px 30px; margin-bottom: 40px; }\n.dbi-art-d20b5e .article-category { display: inline-block; background: rgba(255,255,255,0.2); padding: 8px 20px; border-radius: 25px; font-size: 0.9rem; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-header h1 { font-family: 'Montserrat', sans-serif; font-size: 2.3rem; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-header .subtitle { font-size: 1.1rem; opacity: 0.95; max-width: 700px; margin: 0 auto; }\n.dbi-art-d20b5e .intro-paragraph { font-size: 1.1rem; color: #555; padding: 30px; background: white; border-radius: 15px; border-left: 5px solid #5e5ed7; margin-bottom: 40px; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e h2 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; font-size: 1.9rem; margin: 50px 0 25px; padding-bottom: 15px; border-bottom: 3px solid #a9e2e4; }\n.dbi-art-d20b5e h3 { font-family: 'Montserrat', sans-serif; color: #5268c9; font-size: 1.35rem; margin: 35px 0 15px; }\n.dbi-art-d20b5e p { margin-bottom: 20px; text-align: justify; }\n.dbi-art-d20b5e .highlight-box { background: linear-gradient(135deg, #a9e2e4 0%, #d0f0f2 100%); padding: 30px; border-radius: 15px; margin: 30px 0; }\n.dbi-art-d20b5e .highlight-box h4 { font-family: 'Montserrat', sans-serif; color: #5268c9; margin-bottom: 15px; font-size: 1.2rem; }\n.dbi-art-d20b5e .tip-box { background: linear-gradient(135deg, #ffeca7 0%, #ffe88a 100%); padding: 25px; border-radius: 15px; margin: 25px 0; }\n.dbi-art-d20b5e .tip-box h4 { font-family: 'Montserrat', sans-serif; color: #5268c9; margin-bottom: 10px; }\n.dbi-art-d20b5e .warning-box { background: linear-gradient(135deg, #fde8ee 0%, #fcc8d6 100%); padding: 25px; border-radius: 15px; margin: 25px 0; border-left: 5px solid #e73469; }\n.dbi-art-d20b5e .warning-box h4 { font-family: 'Montserrat', sans-serif; color: #e73469; margin-bottom: 10px; }\n.dbi-art-d20b5e .stats-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 20px; margin: 30px 0; }\n.dbi-art-d20b5e .stat-card { background: white; padding: 25px; border-radius: 15px; text-align: center; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e .stat-number { font-family: 'Montserrat', sans-serif; font-size: 2.5rem; font-weight: 800; color: #5e5ed7; display: block; }\n.dbi-art-d20b5e .stat-label { color: #666; font-size: 0.9rem; margin-top: 8px; }\n.dbi-art-d20b5e .comparison-table { width: 100%; border-collapse: collapse; margin: 30px 0; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 20px rgba(94,94,215,0.1); }\n.dbi-art-d20b5e .comparison-table th { background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 15px 20px; text-align: left; font-family: 'Montserrat', sans-serif; }\n.dbi-art-d20b5e .comparison-table td { padding: 14px 20px; border-bottom: 1px solid #f0f0ff; background: white; vertical-align: top; }\n.dbi-art-d20b5e .comparison-table tr:last-child td { border-bottom: none; }\n.dbi-art-d20b5e .comparison-table tr:nth-child(even) td { background: #f8f8ff; }\n.dbi-art-d20b5e .program-card { background: white; border-radius: 20px; box-shadow: 0 8px 30px rgba(94,94,215,0.15); margin: 40px 0; padding: 30px; }\n.dbi-art-d20b5e .program-card h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; font-size: 1.4rem; margin-bottom: 15px; }\n.dbi-art-d20b5e .cta-button { display: inline-block; background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; padding: 14px 32px; border-radius: 30px; text-decoration: none; font-weight: 600; margin-top: 15px; }\n.dbi-art-d20b5e .method-card { background: white; border-radius: 15px; padding: 28px; margin: 22px 0; box-shadow: 0 5px 20px rgba(94,94,215,0.08); }\n.dbi-art-d20b5e .method-card.blue { border-left: 4px solid #5e5ed7; }\n.dbi-art-d20b5e .method-card.teal { border-left: 4px solid #a9e2e4; }\n.dbi-art-d20b5e .method-card.rose { border-left: 4px solid #e73469; }\n.dbi-art-d20b5e .method-card.yellow { border-left: 4px solid #ffeca7; border-top: 3px solid #ffeca7; }\n.dbi-art-d20b5e .method-card h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 12px; font-size: 1.1rem; }\n.dbi-art-d20b5e .method-card.teal h4 { color: #5268c9; }\n.dbi-art-d20b5e .method-card.rose h4 { color: #e73469; }\n.dbi-art-d20b5e .method-badge { display: inline-block; padding: 4px 12px; border-radius: 20px; font-size: 0.8rem; font-weight: 600; margin-bottom: 12px; }\n.dbi-art-d20b5e .badge-blue { background: #f0f0ff; color: #5e5ed7; }\n.dbi-art-d20b5e .badge-green { background: #e0f7f8; color: #5268c9; }\n.dbi-art-d20b5e .badge-rose { background: #fde8ee; color: #e73469; }\n.dbi-art-d20b5e .badge-yellow { background: #fff8dc; color: #8a6d00; }\n.dbi-art-d20b5e .checklist { background: white; padding: 30px; border-radius: 15px; box-shadow: 0 5px 20px rgba(94,94,215,0.1); margin: 25px 0; }\n.dbi-art-d20b5e .checklist h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 20px; }\n.dbi-art-d20b5e .checklist ul { list-style: none; padding: 0; }\n.dbi-art-d20b5e .checklist li { padding: 10px 0; border-bottom: 1px solid #f0f0ff; padding-left: 35px; position: relative; }\n.dbi-art-d20b5e .checklist li::before { content: '\u2714'; position: absolute; left: 0; color: #5e5ed7; font-weight: bold; }\n.dbi-art-d20b5e .checklist li:last-child { border-bottom: none; }\n.dbi-art-d20b5e .conclusion { background: linear-gradient(135deg, #f5f7fa 0%, #e8e8ff 100%); padding: 40px; border-radius: 20px; margin-top: 50px; }\n.dbi-art-d20b5e .conclusion h2 { border-bottom: none; margin-top: 0; }\n.dbi-art-d20b5e .article-footer { text-align: center; padding: 50px 20px; background: linear-gradient(135deg, #5e5ed7 0%, #5268c9 100%); color: white; border-radius: 30px 30px 0 0; margin-top: 60px; }\n.dbi-art-d20b5e .article-footer h3 { font-family: 'Montserrat', sans-serif; color: white; margin-bottom: 20px; }\n.dbi-art-d20b5e .article-footer a { color: #ffeca7; text-decoration: none; font-weight: 600; }\n.dbi-art-d20b5e .footer-links { display: flex; gap: 20px; justify-content: center; flex-wrap: wrap; margin-top: 15px; }\n.dbi-art-d20b5e .faq-item { background: white; border-radius: 15px; padding: 25px 30px; margin: 15px 0; box-shadow: 0 3px 15px rgba(94,94,215,0.08); border-left: 4px solid #a9e2e4; }\n.dbi-art-d20b5e .faq-item h4 { font-family: 'Montserrat', sans-serif; color: #5e5ed7; margin-bottom: 12px; font-size: 1.05rem; }\n.dbi-art-d20b5e .faq-item p { margin: 0; color: #555; }\n.dbi-art-d20b5e a { color: #5e5ed7; }\n@media (max-width: 768px) {\n.dbi-art-d20b5e .article-header h1 { font-size: 1.8rem; }\n.dbi-art-d20b5e .stats-grid { grid-template-columns: 1fr; }\n.dbi-art-d20b5e .article-header { padding: 40px 15px; }\n.dbi-art-d20b5e .container { padding: 15px; }\n.dbi-art-d20b5e h2 { font-size: 1.5rem; }\n.dbi-art-d20b5e .comparison-table { font-size: 0.9rem; }\n}\n\n<\/style>\n<div class=\"dbi-art-d20b5e\">\n<article>\n<header class=\"article-header\">\n<div class=\"article-category\">\ud83e\udde0 Malattie neurodegenerative \u2014 Serie SEP\/SLA\/Parkinson<\/div>\n<h1>Sclerosi multipla (SEP): sintomi e gestione<\/h1>\n<p class=\"subtitle\">La SEP colpisce 120.000 persone in Francia, principalmente donne giovani. Malattia autoimmune complessa, i suoi sintomi variano da persona a persona e evolvono in modo imprevedibile. Questa guida fa il punto.<\/p>\n<\/header>\n<div class=\"container\">\n<div class=\"intro-paragraph\">\nLa sclerosi multipla \u00e8 una delle malattie neurologiche croniche pi\u00f9 frequenti negli adulti giovani. Prima causa di disabilit\u00e0 non traumatica di origine neurologica prima dei 50 anni in Francia, si caratterizza per un'imprevedibilit\u00e0 che rende il suo accompagnamento particolarmente complesso. Comprendere i suoi meccanismi, le sue forme cliniche e i suoi sintomi \u2014 in particolare i disturbi cognitivi spesso poco conosciuti \u2014 \u00e8 il primo passo per accompagnare efficacemente le persone che ne sono colpite.\n<\/div>\n<div class=\"stats-grid\">\n<div class=\"stat-card\"><span class=\"stat-number\">120 000<\/span><div class=\"stat-label\">persone affette da SEP in Francia \u2014 3 nuove diagnosi al giorno<\/div><\/div>\n<div class=\"stat-card\"><span class=\"stat-number\">85%<\/span><div class=\"stat-label\">dei casi sono di forma ricorrente-remittente \u2014 con riacutizzazioni e remissioni<\/div><\/div>\n<div class=\"stat-card\"><span class=\"stat-number\">40\u201370%<\/span><div class=\"stat-label\">presentano disturbi cognitivi in un momento della malattia<\/div><\/div>\n<\/div>\n\n<h2>1. Meccanismo e definizione<\/h2>\n<p>La SEP \u00e8 una malattia autoimmune in cui il sistema immunitario attacca per errore la <strong>mielina<\/strong>, la guaina isolante che circonda le fibre nervose del sistema nervoso centrale (cervello e midollo spinale). Questo attacco forma placche di demielinizzazione che perturbano o bloccano la trasmissione dei messaggi nervosi. Con il tempo, alcune fibre nervose sono anche danneggiate irreparabilmente \u2014 \u00e8 la neurodegenerazione che genera la disabilit\u00e0 progressiva.<\/p>\n<p>La SEP colpisce preferenzialmente le donne (rapporto di sesso 3:1), con un picco di diagnosi tra i 20 e i 40 anni. La sua eziologia \u00e8 multifattoriale: predisposizione genetica (25% di concordanza tra gemelli monozigoti), fattori ambientali (carenza di vitamina D, fumo, infezione da virus di Epstein-Barr) e fattori immunologici.<\/p>\n\n<h2>2. Le forme cliniche<\/h2>\n<table class=\"comparison-table\">\n<thead><tr><th>Forma<\/th><th>Frequenza<\/th><th>Evoluzione<\/th><\/tr><\/thead>\n<tbody>\n<tr><td><strong>Ricorrente-remittente (RR)<\/strong><\/td><td>85 %<\/td><td>Riacutizzazioni separate da periodi di stabilit\u00e0 (remissioni parziali o complete)<\/td><\/tr>\n<tr><td><strong>Progressiva primaria (PP)<\/strong><\/td><td>15 %<\/td><td>Deterioramento progressivo sin dall'inizio, senza riacutizzazioni distinte<\/td><\/tr>\n<tr><td><strong>Progressiva secondaria (PS)<\/strong><\/td><td>Variabile<\/td><td>Evoluzione da una forma RR verso una progressione continua<\/td><\/tr>\n<\/tbody>\n<\/table>\n\n<h2>3. Sintomi<\/h2>\n\n<div class=\"method-card blue\">\n<div class=\"method-badge badge-blue\">\ud83d\ude34 Fatica neurologica<\/div>\n<h4>La fatica SEP: molto pi\u00f9 della fatica ordinaria<\/h4>\n<p>Presente nell'80% dei pazienti, la fatica nella SEP \u00e8 una fatica neurologica profonda e spesso sproporzionata rispetto allo sforzo. Non si allevia con il riposo, peggiora con il caldo (fenomeno di Uhthoff \u2014 il caldo rallenta ulteriormente la conduzione nervosa demielinizzata) e pu\u00f2 verificarsi anche nei giorni di remissione. \u00c8 spesso il sintomo pi\u00f9 invalidante nella vita quotidiana e professionale.<\/p>\n<\/div>\n\n<div class=\"method-card teal\">\n<div class=\"method-badge badge-green\">\ud83d\udc41\ufe0f Sensitivo e motorio<\/div>\n<h4>Sintomi classici<\/h4>\n<p>I disturbi sensitivi (formicolii, intorpidimenti, dolori neuropatici) sono spesso i primi segni. I <strong>disturbi visivi<\/strong> \u2014 neurite ottica con visione offuscata e dolore oculare \u2014 colpiscono il 20-25% dei pazienti alla prima riacutizzazione. La <strong>spasticit\u00e0<\/strong> (muscoli rigidi e contratti), i <strong>disturbi dell'equilibrio<\/strong> e la <strong>fatica muscolare<\/strong> caratterizzano la progressione.<\/p>\n<\/div>\n\n<div class=\"method-card rose\">\n<div class=\"method-badge badge-rose\">\ud83e\udde0 Cognitivo<\/div>\n<h4>Disturbi cognitivi: la disabilit\u00e0 invisibile della SEP<\/h4>\n<p>40 a 70% delle persone affette da SEP presentano disturbi cognitivi: <strong>rallentamento del trattamento delle informazioni<\/strong> (compiti che richiedono pi\u00f9 tempo), <strong>disturbi della memoria di lavoro<\/strong> (difficolt\u00e0 a trattenere e manipolare informazioni), <strong>disturbi dell'attenzione divisa<\/strong> (difficolt\u00e0 a gestire pi\u00f9 compiti contemporaneamente) e <strong>disturbi delle funzioni esecutive<\/strong>. Questi disturbi sono spesso invisibili ma profondamente impattanti sull'occupazione e sulle relazioni.<\/p>\n<\/div>\n\n<h2>4. Trattamenti<\/h2>\n<p>La gestione della SEP si basa su tre assi. I <strong>trattamenti di fondo<\/strong> (interferoni, acetato di glatiramer, natalizumab, ocrelizumab) riducono la frequenza e la gravit\u00e0 delle riacutizzazioni e rallentano la progressione \u2014 ma non guariscono la malattia. Il <strong>trattamento delle riacutizzazioni<\/strong> (corticosteroidi in infusione) accelera il recupero durante gli episodi acuti. La <strong>riabilitazione e l'accompagnamento sintomatico<\/strong> (fisioterapia, terapia occupazionale, logopedia, neuropsicologia) mantengono la qualit\u00e0 della vita e l'autonomia.<\/p>\n\n<div class=\"program-card\">\n<h4>\ud83e\udde0 Formazioni e strumenti DYNSEO per la SEP<\/h4>\n<p>\u2022 <a href=\"https:\/\/www.dynseo.com\/courses\/sep-et-vie-quotidienne-maintenir-lautonomie-et-prevenir-les-complications\/\" target=\"_blank\"><strong>Formazione \"SEP e vita quotidiana\"<\/strong><\/a> \u2014 mantenere l'autonomia<br>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/courses\/sclerose-en-plaques-en-etablissement-comprendre-la-maladie-et-adapter-sa-pratique-professionnelle\/\" target=\"_blank\"><strong>Formazione \"SEP in istituto\"<\/strong><\/a> \u2014 adattare la propria pratica<br>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/courses\/fatigue-et-troubles-cognitifs-dans-la-sep-ce-que-les-familles-peuvent-faire\/\" target=\"_blank\"><strong>Formazione \"Fatica e disturbi cognitivi nella SEP\"<\/strong><\/a><br>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/test-memoire\/\" target=\"_blank\"><strong>Test Memoria DYNSEO<\/strong><\/a> \u2014 valutare l'impatto cognitivo<br>\n\u2022 <a href=\"https:\/\/www.dynseo.com\/nos-outils\/\" target=\"_blank\"><strong>62 strumenti di stimolazione cognitiva<\/strong><\/a><\/p>\n<a href=\"https:\/\/www.dynseo.com\/courses\/sep-et-vie-quotidienne-maintenir-lautonomie-et-prevenir-les-complications\/\" target=\"_blank\" class=\"cta-button\">Scoprire le formazioni SEP \u2192<\/a>\n<\/div>\n\n<h2>FAQ<\/h2>\n<div class=\"faq-item\"><h4>Che cos'\u00e8 la SEP?<\/h4><p>Malattia autoimmune del sistema nervoso centrale in cui il sistema immunitario attacca la mielina. Colpisce 120.000 persone in Francia, principalmente donne giovani.<\/p><\/div>\n<div class=\"faq-item\"><h4>Quali sono le forme della SEP?<\/h4><p>Ricorrente-remittente (85%, riacutizzazioni e remissioni), progressiva primaria (15%, deterioramento continuo) e progressiva secondaria (evoluzione dalla forma RR).<\/p><\/div>\n<div class=\"faq-item\"><h4>La fatica SEP \u00e8 diversa?<\/h4><p>S\u00ec \u2014 \u00e8 una fatica neurologica profonda, sproporzionata, non alleviata dal riposo, aggravata dal caldo. Colpisce l'80% dei pazienti ed \u00e8 spesso il sintomo pi\u00f9 invalidante.<\/p><\/div>\n<div class=\"faq-item\"><h4>La SEP influisce sulla cognizione?<\/h4><p>S\u00ec \u2014 40-70% dei pazienti presentano disturbi cognitivi: rallentamento, memoria di lavoro, attenzione divisa. Questi disturbi sono spesso invisibili ma profondamente impattanti sull'occupazione e sulla vita sociale.<\/p><\/div>\n<div class=\"faq-item\"><h4>La SEP si guarisce?<\/h4><p>Non ancora. I trattamenti di fondo riducono la frequenza delle riacutizzazioni e rallentano la progressione. La ricerca avanza sulla remielinizzazione.<\/p><\/div>\n\n<div class=\"conclusion\">\n<h2>Conclusione: vivere con la SEP<\/h2>\n<p>La SEP \u00e8 una malattia complessa, imprevedibile e multidimensionale. I suoi sintomi cognitivi, spesso ignorati a favore dei sintomi motori visibili, meritano un'attenzione particolare e un accompagnamento specializzato. DYNSEO propone formazioni per i pazienti, i familiari e i professionisti, oltre a strumenti di stimolazione cognitiva adattati alle esigenze specifiche delle persone affette da SEP.<\/p>\n<\/div>\n\n<\/div>\n<footer class=\"article-footer\">\n<h3>Risorse DYNSEO \u2014 SEP<\/h3>\n<div class=\"footer-links\">\n<a href=\"https:\/\/www.dynseo.com\/courses\/sep-et-vie-quotidienne-maintenir-lautonomie-et-prevenir-les-complications\/\" target=\"_blank\">SEP vita quotidiana<\/a>\n<a href=\"https:\/\/www.dynseo.com\/courses\/fatigue-et-troubles-cognitifs-dans-la-sep-ce-que-les-familles-peuvent-faire\/\" target=\"_blank\">Fatica SEP<\/a>\n<a href=\"https:\/\/www.dynseo.com\/test-memoire\/\" target=\"_blank\">Test Memoria<\/a>\n<a href=\"https:\/\/www.dynseo.com\/nos-outils\/\" target=\"_blank\">62 strumenti<\/a>\n<\/div>\n<\/footer>\n<\/article>\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n\n[et_pb_code]<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Qu'est-ce que la scl\u00e9rose en plaques et comment se d\u00e9veloppe-t-elle ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La scl\u00e9rose en plaques (SEP) est une maladie auto-immune dans laquelle le syst\u00e8me immunitaire attaque par erreur la my\u00e9line, la gaine isolante qui entoure les fibres nerveuses du syst\u00e8me nerveux central (cerveau et moelle \u00e9pini\u00e8re). Cette attaque forme des plaques de d\u00e9my\u00e9linisation qui perturbent ou bloquent la transmission des messages nerveux, entra\u00eenant avec le temps une neurod\u00e9g\u00e9n\u00e9rescence.\"}},{\"@type\":\"Question\",\"name\":\"Combien de personnes sont touch\u00e9es par la SEP en France ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP touche 120 000 personnes en France, principalement des femmes jeunes. On compte environ 3 nouveaux diagnostics par jour. C'est la premi\u00e8re cause de handicap non traumatique d'origine neurologique avant 50 ans en France.\"}},{\"@type\":\"Question\",\"name\":\"Quelle est la forme la plus courante de scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"85% des cas de SEP sont de forme r\u00e9currente-r\u00e9mittente, caract\u00e9ris\u00e9e par des pouss\u00e9es suivies de p\u00e9riodes de r\u00e9mission. Cette forme se distingue par son \u00e9volution impr\u00e9visible avec des phases d'aggravation et d'am\u00e9lioration des sympt\u00f4mes.\"}},{\"@type\":\"Question\",\"name\":\"Les troubles cognitifs sont-ils fr\u00e9quents dans la scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui, 40 \u00e0 70% des personnes atteintes de SEP pr\u00e9sentent des troubles cognitifs \u00e0 un moment de la maladie. Ces troubles cognitifs sont souvent m\u00e9connus mais constituent un aspect important de la maladie qui n\u00e9cessite une prise en charge adapt\u00e9e.\"}},{\"@type\":\"Question\",\"name\":\"Pourquoi dit-on que la SEP est une maladie complexe \u00e0 accompagner ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP est complexe \u00e0 accompagner en raison de son impr\u00e9visibilit\u00e9. Ses sympt\u00f4mes varient d'une personne \u00e0 l'autre et \u00e9voluent de fa\u00e7on impr\u00e9visible, ce qui rend l'accompagnement particuli\u00e8rement difficile et n\u00e9cessite une approche personnalis\u00e9e.\"}},{\"@type\":\"Question\",\"name\":\"Quelle population est principalement touch\u00e9e par la scl\u00e9rose en plaques ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"La SEP touche principalement des femmes jeunes et constitue l'une des maladies neurologiques chroniques les plus fr\u00e9quentes chez les adultes jeunes. Elle repr\u00e9sente la premi\u00e8re cause de handicap non traumatique d'origine neurologique avant l'\u00e2ge de 50 ans.\"}}]}<\/script>[\/et_pb_code]","_et_gb_content_width":"","footnotes":""},"categories":[2915],"tags":[],"class_list":["post-549635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-conseils-des-coachs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/\" \/>\n<meta property=\"og:site_name\" content=\"DYNSEO - App educativa e giochi di memoria\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-17T03:03:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T03:04:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DYNSEO\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"DYNSEO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/\"},\"author\":{\"name\":\"DYNSEO\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#\\\/schema\\\/person\\\/78ef63df2ee64e0989bc68f8401b38d6\"},\"headline\":\"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO\",\"datePublished\":\"2026-04-17T03:03:30+00:00\",\"dateModified\":\"2026-04-17T03:04:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/\"},\"wordCount\":882,\"publisher\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png\",\"articleSection\":[\"Les conseils des coachs\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/\",\"name\":\"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png\",\"datePublished\":\"2026-04-17T03:03:30+00:00\",\"dateModified\":\"2026-04-17T03:04:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png\",\"contentUrl\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png\",\"width\":1080,\"height\":540,\"caption\":\"Giochi di logica digitali per stimolare la mente dei pi\u00f9 piccoli\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/\",\"name\":\"Jeux de m\u00e9moire et stimulation cognitive\",\"description\":\"Con DYNSEO, la tua memoria mette il turbo!\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#organization\",\"name\":\"DYNSEO\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-dynseo-new.png\",\"contentUrl\":\"https:\\\/\\\/www.dynseo.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-dynseo-new.png\",\"width\":5073,\"height\":1397,\"caption\":\"DYNSEO\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/#\\\/schema\\\/person\\\/78ef63df2ee64e0989bc68f8401b38d6\",\"name\":\"DYNSEO\",\"url\":\"https:\\\/\\\/www.dynseo.com\\\/it\\\/author\\\/justine\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/","og_locale":"it_IT","og_type":"article","og_title":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria","og_url":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/","og_site_name":"DYNSEO - App educativa e giochi di memoria","article_published_time":"2026-04-17T03:03:30+00:00","article_modified_time":"2026-04-17T03:04:27+00:00","og_image":[{"width":1080,"height":540,"url":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png","type":"image\/png"}],"author":"DYNSEO","twitter_misc":{"Scritto da":"DYNSEO","Tempo di lettura stimato":"4 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#article","isPartOf":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/"},"author":{"name":"DYNSEO","@id":"https:\/\/www.dynseo.com\/it\/#\/schema\/person\/78ef63df2ee64e0989bc68f8401b38d6"},"headline":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO","datePublished":"2026-04-17T03:03:30+00:00","dateModified":"2026-04-17T03:04:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/"},"wordCount":882,"publisher":{"@id":"https:\/\/www.dynseo.com\/it\/#organization"},"image":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png","articleSection":["Les conseils des coachs"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/","url":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/","name":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO - DYNSEO - App educativa e giochi di memoria","isPartOf":{"@id":"https:\/\/www.dynseo.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#primaryimage"},"image":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png","datePublished":"2026-04-17T03:03:30+00:00","dateModified":"2026-04-17T03:04:27+00:00","breadcrumb":{"@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#primaryimage","url":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png","contentUrl":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2025\/04\/DYNSEO-demande-de-PCH-avec-nos-programme-de-jeux-de-memoire4.png","width":1080,"height":540,"caption":"Giochi di logica digitali per stimolare la mente dei pi\u00f9 piccoli"},{"@type":"BreadcrumbList","@id":"https:\/\/www.dynseo.com\/it\/sclerosi-multipla-sep-sintomi-e-gestione-dynseo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.dynseo.com\/it\/"},{"@type":"ListItem","position":2,"name":"Sclerosi multipla (SEP): sintomi e gestione | DYNSEO"}]},{"@type":"WebSite","@id":"https:\/\/www.dynseo.com\/it\/#website","url":"https:\/\/www.dynseo.com\/it\/","name":"Jeux de m\u00e9moire et stimulation cognitive","description":"Con DYNSEO, la tua memoria mette il turbo!","publisher":{"@id":"https:\/\/www.dynseo.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dynseo.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.dynseo.com\/it\/#organization","name":"DYNSEO","url":"https:\/\/www.dynseo.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.dynseo.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2022\/05\/logo-dynseo-new.png","contentUrl":"https:\/\/www.dynseo.com\/wp-content\/uploads\/2022\/05\/logo-dynseo-new.png","width":5073,"height":1397,"caption":"DYNSEO"},"image":{"@id":"https:\/\/www.dynseo.com\/it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.dynseo.com\/it\/#\/schema\/person\/78ef63df2ee64e0989bc68f8401b38d6","name":"DYNSEO","url":"https:\/\/www.dynseo.com\/it\/author\/justine\/"}]}},"_links":{"self":[{"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/posts\/549635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/comments?post=549635"}],"version-history":[{"count":2,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/posts\/549635\/revisions"}],"predecessor-version":[{"id":549637,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/posts\/549635\/revisions\/549637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/media\/150367"}],"wp:attachment":[{"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/media?parent=549635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/categories?post=549635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dynseo.com\/it\/wp-json\/wp\/v2\/tags?post=549635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}